Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Oncology Devices Market by Type (Rachytherapy Devices, Endoscopic Devices), By Application (Cancer Research Institutes, Cancer Hospitals) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Oncology Devices Market by Type (Rachytherapy Devices, Endoscopic Devices), By Application (Cancer Research Institutes, Cancer Hospitals) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137784 3300 Medical Devices & Consumables 377 239 Pages 4.8 (47)

Market Overview:

The global oncology devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, technological advancements in oncology devices, and rising demand for minimally invasive procedures. Based on type, the rachytherapy devices segment is expected to account for the largest share of the global oncology devices market in 2018. This segment is projected to grow at a CAGR of 8% from 2018 to 2030. The growth in this segment can be attributed to the increasing use of rachytherapy as a treatment modality for various types of cancer. Based on application, cancer research institutes are expected to account for the largest share of the global oncology devices market in 2018.

Global Oncology Devices Industry Outlook

Product Definition:

Oncology Devices are used in the diagnosis and treatment of cancer. They include devices such as x-ray machines, chemotherapy drugs, and radiation therapy machines.

Rachytherapy Devices:

Rachytherapy is a radiation therapy used to treat cancer. It's majorly used for prostate, cervical, lung and breast cancers. The treatment involves placing radioactive materials inside the body which then emit radiation on command by the medical practitioner. Rachytherapy can be done in two ways: external beam and intraoperative radiotherapy.

Endoscopic Devices:

Endoscopic devices are medical devices used for visualizing and removing objects from the body. These include cameras, forceps, snare wires, stethoscopes (hearing aids), thermometers, laparoscopes (surgery), cannula & suction pumps and other accessories.

Application Insights:

The cancer research institutes segment dominated the global oncology devices market in 2017. This can be attributed to factors such as increasing government funding for cancer research and rising prevalence of cancer across the globe. According to WHO, an estimated 9.6 million people died from cancer in 2016, which represented 22% of all deaths worldwide. In addition, an estimated 1.7 million people were diagnosed with new cases of lung, breast and colorectal cancers that year globally (excluding China).

Cancer hospitals are anticipated to witness lucrative growth over the forecast period owing to increasing number of approvals for novel equipment by regulatory authorities such as FDA (U.S.) and European Commission (EU) pertaining to chemoradiation therapy (CRT), robotic surgery systems and image-guided radiation therapy systems among others over the past few years due to technological advancements coupled with continuous R&D initiatives by major players such as Siemens Healthineers LLC; Stryker Corporation; GE Healthcare Ltd.

Regional Analysis:

North America dominated the global oncology devices market in 2017. This can be attributed to presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and government support for cancer research & development. For instance, as per the National Cancer Institute (NCI), there were 1.9 million new cases of cancer reported in the U.S., with prostate being most commonly diagnosed followed by breast and lung cancers.

Growth Factors:

  • Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for oncology devices market. According to World Health Organization (WHO), the number of new cases of cancer is expected to rise from 14 million in 2012 to 22 million by 2030. This will create demand for oncology devices and boost the growth of this market.
  • Rising awareness about early detection and treatment: There is an increasing awareness among people about early detection and treatment options for cancer, which is driving the demand for oncology devices. People are now more inclined towards seeking medical help at an early stage, which is resulting in increased adoption of oncology devices.
  • Technological advancements: The technological advancements in oncology devices are helping healthcare professionals to detect and treat cancers at an earlier stage, thus improving patient outcomes significantly. This is fuelling the growth of this market considerably across the globe.

Scope Of The Report

Report Attributes

Report Details

Report Title

Oncology Devices Market Research Report

By Type

Rachytherapy Devices, Endoscopic Devices

By Application

Cancer Research Institutes, Cancer Hospitals

By Companies

GE Healthcare, Medtronic, Varian Medical Systems, Elekta, Theragenics Corporation, Accuray, Elekta, Theragenics Corporation, Eckert & Ziegler BEBIG

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Oncology Devices Market Report Segments:

The global Oncology Devices market is segmented on the basis of:


Rachytherapy Devices, Endoscopic Devices

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Cancer Research Institutes, Cancer Hospitals

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GE Healthcare
  2. Medtronic
  3. Varian Medical Systems
  4. Elekta
  5. Theragenics Corporation
  6. Accuray
  7. Elekta
  8. Theragenics Corporation
  9. Eckert & Ziegler BEBIG

Global Oncology Devices Market Overview

Highlights of The Oncology Devices Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Rachytherapy Devices
    2. Endoscopic Devices
  1. By Application:

    1. Cancer Research Institutes
    2. Cancer Hospitals
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Oncology Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Oncology Devices Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Oncology devices are medical devices used in oncology treatments. They include radiation therapy machines, chemotherapy drugs, and other equipment used to fight cancer.

Some of the key players operating in the oncology devices market are GE Healthcare, Medtronic, Varian Medical Systems, Elekta, Theragenics Corporation, Accuray, Elekta, Theragenics Corporation, Eckert & Ziegler BEBIG.

The oncology devices market is expected to register a CAGR of 7.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Oncology Devices Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Oncology Devices Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Oncology Devices Market - Supply Chain
   4.5. Global Oncology Devices Market Forecast
      4.5.1. Oncology Devices Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Oncology Devices Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Oncology Devices Market Absolute $ Opportunity

5. Global Oncology Devices Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Oncology Devices Market Size and Volume Forecast by Type
      5.3.1. Rachytherapy Devices
      5.3.2. Endoscopic Devices
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Oncology Devices Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Oncology Devices Market Size and Volume Forecast by Application
      6.3.1. Cancer Research Institutes
      6.3.2. Cancer Hospitals
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Oncology Devices Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Oncology Devices Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Oncology Devices Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Oncology Devices Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Oncology Devices Demand Share Forecast, 2019-2029

9. North America Oncology Devices Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Oncology Devices Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Oncology Devices Market Size and Volume Forecast by Application
      9.4.1. Cancer Research Institutes
      9.4.2. Cancer Hospitals
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Oncology Devices Market Size and Volume Forecast by Type
      9.7.1. Rachytherapy Devices
      9.7.2. Endoscopic Devices
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Oncology Devices Demand Share Forecast, 2019-2029

10. Latin America Oncology Devices Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Oncology Devices Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Oncology Devices Market Size and Volume Forecast by Application
      10.4.1. Cancer Research Institutes
      10.4.2. Cancer Hospitals
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Oncology Devices Market Size and Volume Forecast by Type
      10.7.1. Rachytherapy Devices
      10.7.2. Endoscopic Devices
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Oncology Devices Demand Share Forecast, 2019-2029

11. Europe Oncology Devices Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Oncology Devices Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Oncology Devices Market Size and Volume Forecast by Application
      11.4.1. Cancer Research Institutes
      11.4.2. Cancer Hospitals
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Oncology Devices Market Size and Volume Forecast by Type
      11.7.1. Rachytherapy Devices
      11.7.2. Endoscopic Devices
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Aalysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Oncology Devices Demand Share, 2019-2029

12. Asia Pacific Oncology Devices Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Oncology Devices Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Oncology Devices Market Size and Volume Forecast by Application
      12.4.1. Cancer Research Institutes
      12.4.2. Cancer Hospitals
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Oncology Devices Market Size and Volume Forecast by Type
      12.7.1. Rachytherapy Devices
      12.7.2. Endoscopic Devices
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Oncology Devices Demand Share, 2019-2029

13. Middle East & Africa Oncology Devices Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Oncology Devices Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Oncology Devices Market Size and Volume Forecast by Application
      13.4.1. Cancer Research Institutes
      13.4.2. Cancer Hospitals
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Oncology Devices Market Size and Volume Forecast by Type
      13.7.1. Rachytherapy Devices
      13.7.2. Endoscopic Devices
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Oncology Devices Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Oncology Devices Market: Market Share Analysis
   14.2. Oncology Devices Distributors and Customers
   14.3. Oncology Devices Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GE Healthcare Overview Financials Developments Strategic Outlook
      14.4.2. Medtronic Overview Financials Developments Strategic Outlook
      14.4.3. Varian Medical Systems Overview Financials Developments Strategic Outlook
      14.4.4. Elekta Overview Financials Developments Strategic Outlook
      14.4.5. Theragenics Corporation Overview Financials Developments Strategic Outlook
      14.4.6. Accuray Overview Financials Developments Strategic Outlook
      14.4.7. Elekta Overview Financials Developments Strategic Outlook
      14.4.8. Theragenics Corporation Overview Financials Developments Strategic Outlook
      14.4.9. Eckert & Ziegler BEBIG Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us